Patents by Inventor Luchy D. Roteliuk

Luchy D. Roteliuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8905939
    Abstract: A method and apparatus for determining a cardiovascular parameter including receiving an input signal corresponding to an arterial blood pressure measurement over an interval that covers at least one cardiac cycle, determining a propagation time of the input signal, determining at least one statistical moment of the input signal, and determining an estimate of the cardiovascular parameter using the propagation time and the at least one statistical moment.
    Type: Grant
    Filed: November 6, 2006
    Date of Patent: December 9, 2014
    Assignee: Edwards Lifesciences Corporation
    Inventors: Feras S. Hatib, Charles R. Mooney, Luchy D. Roteliuk
  • Publication number: 20080033305
    Abstract: A method and apparatus for determining a cardiovascular parameter including receiving an input signal corresponding to an arterial blood pressure measurement over an interval that covers at least one cardiac cycle, determining a propagation time of the input signal, determining at least one statistical moment of the input signal, and determining an estimate of the cardiovascular parameter using the propagation time and the at least one statistical moment.
    Type: Application
    Filed: November 6, 2006
    Publication date: February 7, 2008
    Inventors: Feras S. Hatib, Charles R. Mooney, Luchy D. Roteliuk
  • Publication number: 20080015451
    Abstract: A method and apparatus for determining a cardiovascular parameter including receiving an input signal corresponding to an arterial blood pressure measurement over an interval that covers at least one cardiac cycle, determining a propagation time of the input signal, determining at least one statistical moment of the input signal, and determining an estimate of the cardiovascular parameter using the propagation time and the at least one statistical moment.
    Type: Application
    Filed: July 6, 2007
    Publication date: January 17, 2008
    Inventors: Feras S. Hatib, Charles R. Mooney, Luchy D. Roteliuk
  • Patent number: 6398782
    Abstract: The method, device and system for electrical sealing of a puncture opening in a blood vessel wall. In a first embodiment, a vascular sealing probe has two bipolar electrodes formed thereon, is insertable to a position whereat the bipolar tip is adjacent the blood vessel puncture site to effect electrocauterization or electrocoagulation of the puncture site. In a second embodiment the bipolar vascular sealing probe has a first electrode formed thereon and an electrode-guide wire has the second bipolar electrode formed thereon. The electrode-guide wire is passable through a lumen formed in the probe such that the second electrode on the electrode-guide wire is positioned close enough to the first electrode positioned on the probe to permit electrical current to pass therebetween.
    Type: Grant
    Filed: May 15, 1995
    Date of Patent: June 4, 2002
    Assignee: Edwards Lifesciences Corporation
    Inventors: Robert Pecor, Timothy C. Mills, Howard Taymor-Luria, Clifford E. Currier, Mark A. Konno, Charles R. Mooney, David J. Evans, Luchy D. Roteliuk
  • Patent number: 6371923
    Abstract: The invention estimates a cardiac performance value such as cardiac output (CO) and cardiac ejection fraction (EF) by sensing a downstream indicator concentration signal y(t) that corresponds to an indicator (preferably heat) signal x(t) injected upstream in a patient's blood channel. The signal x(t) is preferably generated as a series of alternating transitions between a high state and a low state, such as a PRBS signal. The signal y(t) is then divided into at least one sub-signal that is synchronous with x(t). A decay parameter &tgr; that minimizes a cost function that includes a time-domain channel relaxation model is then calculated. The cardiac performance value is then calculated based on this value for &tgr;. For each transition of the injected indicator signal, a corresponding segment of the indicator concentration signal is preferably isolated, and a segment relaxation parameter is then calculated.
    Type: Grant
    Filed: December 7, 1999
    Date of Patent: April 16, 2002
    Assignee: Edwards Lifesciences Corporation
    Inventors: Luchy D. Roteliuk, Russell McKown
  • Patent number: 6045512
    Abstract: The cardiac ejection fraction EF is estimated based on the parameters of a model of an indicator (such as thermal) dilution through the heart. A channel model is defined by an upstream indicator injector, such as a heater, positioned preferably in the right atrium/ventricle and a downstream indicator concentration sensor, such as a thermistor. The preferred model is a lagged normal transfer function, which has as one of its output parameters the indicator decay constant .tau. of the blood channel. The heart rate HR is also measured. The ejection fraction EF is then calculated continuously as EF=1-exp(-60/(.tau.*HR)). The cardiac output CO is also estimated in the model, preferably based on an estimate of the zero-frequency gain of the lagged normal transfer function. End diastolic volume EDV is then also calculated continuously as a function of CO, HR and EF.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: April 4, 2000
    Assignee: Baxter International Inc.
    Inventors: Luchy D. Roteliuk, Russell McKown